Resumen

QUINTERO-SIERRA, Yamilé; MUSTELIER-CELZA, Gelquin L; HERNANDEZ-PADRON, Carlos  y  ROMERO-GONZALEZ, Adrián. Chronic myelomonocytic leukemia. Rev Cubana Hematol Inmunol Hemoter [online]. 2014, vol.30, n.4, pp.306-312. ISSN 0864-0289.

Chronic myelomonocytic leukemia is a clonal hematopoietic stem cell disorder classified as a myelodysplastic/myeloproliferative neoplasm. It is characterized by absolute monocytosis (>1.0 x 10⁹/ L) in the peripheral blood that persists for at least 3 months, with dysplastic and myeloproliferation in the bone marrow. Patients may show symptoms related to cytopenias and hypercatabolic state with splenomegaly. The diagnosis is established by combination of complete blood count, peripheral blood smear, bone marrow aspirate, bone marrow biopsy, immunophenotypic profile and study of molecular abnormalities. The prognosis is bad. The treatment of election is the hematopoietic allogeneic stem cell transplantation with regimen of reduced toxicity. In around 30 % of these patients the disease transforms to acute myeloid leukemia.

Palabras clave : chronic myelomonocytic leukemia; myelodysplastic/myeloproliferative neoplasm.